Inmaculada Jiménez‐Nácher

1.4k citations

27 papers · 992 indexed · h-index 18

Co-authors: Vincent Soriano Daniel González de Requena Juan González‐Lahoz Pablo Barreiro Sonia Rodríguez‐Nóvoa Marina Núñez Luz Martı́n-Carbonero Gema González‐Pardo
Topics: HIV/AIDS drug development and treatment (24 papers)HIV Research and Treatment (14 papers)Hepatitis C virus research (12 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: Clinical Infectious Diseases The Journal of Infectious Diseases Antimicrobial Agents and Chemotherapy
Partner nations: Spain China United States

In The Last Decade

Inmaculada Jiménez‐Nácher

27 papers receiving 908 citations

Peers

Countries citing papers authored by Inmaculada Jiménez‐Nácher

Since Specialization

Citations

This map shows the geographic impact of Inmaculada Jiménez‐Nácher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Jiménez‐Nácher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Jiménez‐Nácher more than expected).

Fields of papers citing papers by Inmaculada Jiménez‐Nácher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Jiménez‐Nácher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Jiménez‐Nácher. The network helps show where Inmaculada Jiménez‐Nácher may publish in the future.

Co-authorship network of co-authors of Inmaculada Jiménez‐Nácher

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Jiménez‐Nácher. A scholar is included among the top collaborators of Inmaculada Jiménez‐Nácher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Jiménez‐Nácher. Inmaculada Jiménez‐Nácher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients 2011 ·Expert Opinion on Drug Metabolism & Toxicology ·Inmaculada Jiménez‐Nácher,Elena Álvarez,Judit Morelló,Sonia Rodríguez‐Nóvoa,(unknown),Vincent Soriano	31
2	Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon–Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection 2010 ·The Journal of Infectious Diseases ·Judit Morelló,Lorena Cuenca‐Bermejo,Vincent Soriano,J. Medraño,Antonio Madejón,Eugenia Vispo,Pablo Barreiro,Pablo Labarga,Inmaculada Jiménez‐Nácher,Sonia Rodríguez‐Nóvoa	30
3	Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected Patients 2009 ·Clinical Infectious Diseases ·J. Medraño,Pablo Barreiro,Salvador Resino,Paula Tuma,Violeta J. Rodriguez,Eugenia Vispo,Pablo Labarga,Antonio Madejón,Javier García‐Samaniego,Inmaculada Jiménez‐Nácher,Luz Martı́n-Carbonero,Vincent Soriano	30
4	Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C 2009 ·Journal of Antimicrobial Chemotherapy ·Eugenia Vispo,(unknown),Ivana Maida,Francisco J. Blanco,Marta Córdoba,Pablo Labarga,Sonia Rodríguez‐Nóvoa,Elena Álvarez,Inmaculada Jiménez‐Nácher,Vincent Soriano	40
5	Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring 2008 ·AIDS Research and Human Retroviruses ·Sonia Rodríguez‐Nóvoa,Judit Morelló,Pablo Barreiro,Ivana Maida,Pilar García‐Gascó,Eugenia Vispo,Gema González‐Pardo,Antonio Fernández Parra,Inmaculada Jiménez‐Nácher,Vincent Soriano	31
6	Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin 2008 ·AIDS ·Sonia Rodríguez‐Nóvoa,Judit Morelló,(unknown),Eugenia Vispo,Pablo Barreiro,Gema González‐Pardo,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	33
7	Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study 2007 ·AIDS Research and Human Retroviruses ·Matilde Sánchez‐Conde,Rosario Palacios,José Sanz,Sonia Rodríguez‐Nóvoa,Pablo Rivas,Jesús Santos,Julio Sola,Víctor Asensi,Carmen de Mendoza,Vicente Estrada,Pablo Barreiro,Juan González‐Lahoz,Inmaculada Jiménez‐Nácher,Vincent Soriano	8
8	Value of the HLA-B5701 Allele to Predict Abacavir Hypersensitivity in Spaniards 2007 ·AIDS Research and Human Retroviruses* ·Sonia Rodríguez‐Nóvoa,Pilar García‐Gascó,Francisco J. Blanco,Gema González‐Pardo,Carol Castellares,(unknown),Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	23
9	Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients 2007 ·AIDS Research and Human Retroviruses ·Carmen de Mendoza,Carmen Garrido,Angélica Corral,Germán Ramírez‐Olivencia,Inmaculada Jiménez‐Nácher,Natalia Zahonero,Juan González‐Lahoz,Vincent Soriano	30
10	Drug Interactions of Tipranavir, a New HIV Protease Inhibitor 2007 ·Drug Metabolism Letters ·Judit Morelló,Sonia Rodríguez‐Nóvoa,Inmaculada Jiménez‐Nácher,Vincent Soriano	8
11	Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia 2006 ·AIDS ·Sonia Rodríguez‐Nóvoa,Luz Martı́n-Carbonero,Pablo Barreiro,Gema González‐Pardo,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	126
12	Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients 2005 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Ana Lucía Rendón,Marina Núñez,Míriam Romero,Pablo Barreiro,Luz Martı́n-Carbonero,Javier García‐Samaniego,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	61
13	Short Communication: Changes in Nevirapine Plasma Concentrations Over Time and Its Relationship with Liver Enzyme Elevations 2005 ·AIDS Research and Human Retroviruses ·Daniel González de Requena,Inmaculada Jiménez‐Nácher,Vincent Soriano	24
14	Prediction of Virological Response to Lopinavir/Ritonavir Using the Genotypic Inhibitory Quotient 2004 ·AIDS Research and Human Retroviruses ·Daniel González de Requena,Óscar Gallego,(unknown),Inmaculada Jiménez‐Nácher,Vincent Soriano	51
15	Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations 2004 ·AIDS ·Daniel González de Requena,Óscar Gallego,Angélica Corral,Inmaculada Jiménez‐Nácher,Vincent Soriano	12
16	Indinavir Plasma Concentrations and Resistance Mutations in Patients Experiencing Early Virological Failure 2003 ·AIDS Research and Human Retroviruses ·Daniel González de Requena,Óscar Gallego,Carmen de Mendoza,Angélica Corral,Inmaculada Jiménez‐Nácher,Vincent Soriano	13
17	Correlation Between Lopinavir Plasma Levels and Lipid Abnormalities in Patients Taking Lopinavir/Ritonavir 2003 ·AIDS Patient Care and STDs ·Daniel González de Requena,Francisco J. Blanco,Teresa García-Benayas,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	55
18	Liver toxicity caused by nevirapine 2002 ·AIDS ·Daniel González de Requena,Marina Núñez,Inmaculada Jiménez‐Nácher,Vincent Soriano	138
19	Higher Efavirenz Plasma Levels Correlate With Development of Insomnia 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Marina Núñez,Daniel González de Requena,Lucía Gallego,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz,Vincent Soriano	1
20	Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids 2000 ·AIDS ·Pablo Barreiro,Vincent Soriano,E Casas,Vicente Estrada,María Jesús Téllez,Richard M. W. Hoetelmans,Daniel González de Requena,Inmaculada Jiménez‐Nácher,Juan González‐Lahoz	65

About Inmaculada Jiménez‐Nácher

Inmaculada Jiménez‐Nácher is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 27 papers that have together received 992 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (12 papers). The work is most often cited by research in Virology (461 citations), Infectious Diseases (759 citations) and Hepatology (299 citations). Inmaculada Jiménez‐Nácher has collaborated with scholars based in Spain, China and United States. Frequent co-authors include Vincent Soriano, Daniel González de Requena, Juan González‐Lahoz, Pablo Barreiro, Sonia Rodríguez‐Nóvoa, Marina Núñez, Luz Martı́n-Carbonero, Gema González‐Pardo, Óscar Gallego and Judit Morelló. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact